Pia GATTINGER, PhD
Department of Pathophysiology and Allergy Research, Division of Immunopathology
Center for Pathophysiology, Infectiology and Immunology
Medical University of Vienna, Austria
Education:
Diplom-Ingenieur: University of Natural Resources and Life Sciences, Vienna
PhD degree: Medical University of Vienna
Research Interests:
• Analysis and characterization of disease-causing antigens
• Investigation of disease pathomechanisms
• Development of analytic tools and antigen-specific forms of therapy and prevention
• Identify protective antibody and cellular responses and to develop safe vaccines
Biography:
Pia Gattinger is Postdoctoral Researcher at the Department of Pathophysiology and Allergy Research. She received her Venia Docendi in Medical Biotechnology. Dr. Pia Gattinger focuses on the investigation of insect venom allergy and the role of carbohydrates in allergy and she developed novel strategies for the serological diagnosis of venom allergy and the improvement of molecular allergy diagnosis. Additionally, Dr. Gattinger is deciphering the immune response after infections and vaccinations. She is interested in the development of vaccines for the prevention of allergy and infectious diseases and investigation of novel forms of treatment. Dr. Gattinger received training in “Adjuvants and Vaccine Formulation” at the Vaccine Formulation Institute (VFI), Geneva, Switzerland and is Editorial Board Member of “Allergy”.
Dr. Pia Gattinger has been awarded several awards, like the Life Science Research Award Austria in the category “Applied Research” of the Austrian Association of Molecular Life Sciences and Biotechnology and the Researcher of the Month Award of the Medical University of Vienna and is alumna of the 72th Lindau Nobel Laureate Meeting.
Selected publications:
- Gattinger P, Lupinek C, Kalogiros L, Silar M, Zidarn M, Korosec P, Koessler C, Novak N, Valenta R, Mittermann I. The culprit insect but not severity of allergic reactions to bee and wasp venom can be determined by molecular diagnosis. PLoS One. 2018 Jun 25;13(6):e0199250. doi: 10.1371/journal.pone.0199250
- Gattinger P, Mittermann I, Lupinek C, Hofer G, Keller W, Bidovec Stojkovic U, Korosec P, Koessler C, Novak N, Valenta R. Recombinant glycoproteins resembling carbohydrate-specific IgE epitopes from plants, venoms and mites. EBioMedicine. 2019 Jan;39:33-43. doi: 10.1016/j.ebiom.2018.12.002
- Gattinger P, Bidovec-Stojkovic U, Zidarn M, Korosec P, Valenta R, Mittermann I. Glycosylation enhances allergenic activity of major bee venom allergen Api m 1 by adding IgE epitopes. J Allergy Clin Immunol. 2021 Apr;147(4):1502-1504.e5. doi: 10.1016/j.jaci.2020.10.002.
- Gattinger P, Niespodziana K, Stiasny K, Sahanic S, Tulaeva I, Borochova K, Dorofeeva Y, Schlederer T, Sonnweber T, Hofer G, Kiss R, Kratzer B, Trapin D, Tauber PA, Rottal A, Körmöczi U, Feichter M, Weber M, Focke-Tejkl M, Löffler-Ragg J, Mühl B, Kropfmüller A, Keller W, Stolz F, Henning R, Tancevski I, Puchhammer-Stöckl E, Pickl WF, Valenta R. Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes. Allergy. 2022 Jan;77(1):230-242. doi: 10.1111/all.15066
- Gattinger P, Kratzer B, Tulaeva I, Niespodziana K, Ohradanova-Repic A, Gebetsberger L, Borochova K, Garner-Spitzer E, Trapin D, Hofer G, Keller W, Baumgartner I, Tancevski I, Khaitov M, Karaulov A, Stockinger H, Wiedermann U, Pickl WF, Valenta R. Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants. Allergy. 2022 Aug;77(8):2431-2445. doi: 10.1111/all.15305
